Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

Improving long-term survival for organ transplant patients

Official title: Optimizing Long-term Survival in Organ Transplantation: From Physiopathology to Optimized Patient Management

Run by University Hospital, Limoges · NCT03997253 · Data updated 2026-11-12

This study is testing ways to improve the long-term success of organ transplants by personalizing care and collecting samples from patients to better predict and prevent transplant rejection.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment430 (estimated)
SponsorUniversity Hospital, Limoges
Academic / other
Locations4 sites (Limoges and 3 other locations)
StatusRecruiting
StartedDecember 21, 2020
Main results expectedJune 2027
Study endsJune 2027
Registry record updatedJune 29, 2026
Trial IDNCT03997253 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 who have received a kidney, liver, or heart transplant and are being followed by one of the participating FHU SUPORT centers.

Probably not a fit

Patients who are unable to understand the information provided or are under legal protection may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance the long-term success of organ transplantation by optimizing donor and recipient management and personalizing follow-up care. It focuses on identifying factors that contribute to long-term graft and patient survival through translational research and biological sample collection. Participants will provide blood and urine samples to help predict transplant rejection and improve patient outcomes.

Why it matters

Potential benefit: If successful, this study could significantly improve the long-term survival rates and quality of life for organ transplant recipients.

How similar studies have gone: Other studies have shown promise in optimizing organ transplant outcomes through personalized management strategies, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female over 18 (no age limit)
* affiliated to a social security organization
* Recipient (s) of a kidney, liver or heart transplant
* followed by at least one of the FHU SUPORT centers (Tours, Poitiers, Limoges, Rennes)
* having given informed consent to participate in the cohort.

Exclusion Criteria:

* Patient unable to understand the information given by the investigator
* People under the protection of justice

Where it's running

  • Limoges hospital
    Limoges, France
    Recruiting
  • Poitiers Hospital
    Poitiers, France
    Recruiting
  • Tours hospital
    Tours, France
    Recruiting
  • Rennes Hospital
    Rennes, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.